The aim of the present study was to investigate the protective role of hyperoxia liquid in regulating cardiopulmonary bypass (CPB)-induced myocardial damage and its possible underlying mechanism. In the CPB-induced rat model, hyperoxia liquid enhanced left ventricular ejection fraction (LVEF), reduced the left ventricular internal dimension systole (LVIDs) level, inhibited malondialdehyde levels, increased superoxide dismutase, glutathione (GSH) and GSH peroxidase levels, suppressed heart cell apoptosis, and induced the nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) signaling pathway. Then, ML385, a Nrf2 inhibitor, was used to attenuate the effect of hyperoxia liquid on LVEF and LVIDs levels, oxidative stress and heart cell apoptosis in the CPB-induced rat model. Collectively, the results of the present study demonstrated that the protective role of hyperoxia liquid may regulate oxidative stress in a CPB-induced rat model through the Nrf2-antioxidant response element signaling pathway.
Introduction
Hyperoxia liquids (HOS) is medical liquid containing high concentration of dissolved oxygen (DO). HOS is mainly prepared using the electrochemistry and rapid physical replacement of DO mechanisms. A large amount of O 2 and little O 3 are dissolved into the commonly used medical liquid in clinic. The oxygen partial pressure in the liquid is 153.7 mmHg and the DO content is 3.8 mmg before oxygen dissolving. However, the oxygen partial pressure has reached 795 mmHg after oxygen dissolving. Meanwhile, its O 2 content is 5.3-fold of that of conventional liquid, as well as 8.3-fold and 21.3-fold of that in arterial and venous blood, respectively. The O 3 concentration in the hyperoxic fluid measured immediately after oxygen dissolving using iodimetry is 26.5 µg/ml. 20 min later, O 3 is completely reduced to the dissolved O 2 . HOS can directly improve the blood oxygen partial pressure and blood DO content after it enters the blood. Meanwhile, it can indirectly enhance the chemically bonded oxygen (oxygen saturation). Currently, HOS is used in auxiliary oxygen supply treatment for multiple diseases with hypoxic symptoms. They include the first-aid in critical patients, cardiopulmonarycerebral resuscitation, central respiration repression, as well as severe head and face combined injury. In addition, it is also used in respiratory tract burn, pulmonary interstitial fibrosis, coal pneumoconiosis, pneumoconiosis, respiratory failure, one-lung ventilation during thoracic surgery, cerebral ischemia, myocardial ischemia, severe acute respiratory syndrome and high altitude hypoxia. Notably, favorable auxiliary effects have been attained.
Cardiopulmonary bypass (CPB) has been applied in cardiac and major vascular surgery for over half a century. Understanding towards CPB professional theoretical knowledge has been enhanced in recent years (1) . In addition, medical materials, management level and surgical techniques have been improved (1) . Therefore, the postoperative mortality and incidence of complications have been greatly reduced (2) . This contributes to saving the lives of millions of patients. However, the CPB injury to the heart remains a research hotspot (2) . According to literature report, the incidence of arrhythmia after CPB is related to underlying disease, surgical type and intraoperative myocardial protection (3). The incidence after surgery for congenital heart disease is 40-60%, while that after valve replacement for valvular heart disease is 70-84%. It has extended the length of stay in patients (3) . Moreover, it will add to the incidence of complications and risk of death (4). Thus, it will cause tremendous economic burdens on both the family and the society. The mechanism of CPB in cardiac injury is quite complicated. It is mainly induced by cardiac ischemic The effects of hyperoxia liquid regulate cardiopulmonary bypass-induced myocardial damage through the Nrf2-ARE signaling pathway damage, ventricular hyperinflation or emptiness, ascending aorta blocking and ischemia/reperfusion (I/R) injury (4) . Myocardial ischemia injury refers to abnormal myocardial energy metabolism, myocardial structural and functional changes derived (5) from reduced cardiac blood supply and hypoxidosis. Its pathogenesis is related to multi-layer and multi-target factors. Clinical and experimental studies suggest that oxidative stress plays a vital role in the genesis and development of myocardial ischemic injury diseases (6) . Myocardial ischemia is accompanying with excessive production and accumulation of reactive oxygen species (ROS). It will induce endogenous oxidative stress and lipid peroxidation of unsaturated fatty acid on myocardial cell membrane (6) . On the one hand, it will promote myocardial cell apoptosis and myocardial tissue necrosis. On the other hand, it will lead to changed cell membrane permeability and fluidity. Therefore, it will induce leakage of excessive intracellular myocardial enzymes and aggravate myocardial ischemia injury (7) . Thus, effective intervention of the endogenous oxidative stress is an important pathway for improving myocardial ischemia injury and protecting myocardial tissue (7) .
The nuclear factor erythroid 2-related factor 2 (Nrf2) pathway is the most important endogenous anti-oxidative stress pathway discovered recently (8) . It plays a pivotal role in response to oxidative stress. Moreover, it is extensively distributed in the cardiovascular system (8) . It is also closely related to improving myocardial ischemia injury. Generally, it exerts its anti-oxidative effect through two aspects (9) . On the one hand, oxidative stress can promote Nrf2 mRNA transcription and increase Nrf2 protein synthesis (8) . On the other hand, Nrf2 dissociates with its chaperonin Keap1 in the case of electrophilic substance, ROS or upstream signaling pathway stimulation (8) . As a result, increased amount of Nrf2 transfers from cytoplasm to cell nucleus. Subsequently, it binds with antioxidant response element (ARE) in the form of heterodimer with tendon fibrosarcoma protein (8, 10) . Later, it up-regulates the expression of the downstream phase II detoxifying enzyme and antioxidase genes NQO1 and heme oxygenase-1 (HO-1). Thus, it can alleviate oxidative stress injury. HO-1 reduced prooxidant and attenuate cardiac hypertrophy through ROS production. Nrf2 upregulates HO-1 in different cell models to suppress oxidative stress in different cell. The protective role of hyperoxia liquid regulates CPB-induced myocardial damage and its possible mechanism.
Materials and methods
Animals and treatment. Thirty adult male Sprague-Dawley rats (200-230 g) were purchased from the Center of Experimental Animal in Shandong Provincial Hospital Affiliated to Shandong University and were housed in individual cages with free access to food and water and maintained at an ambient temperature of 22±2˚C, on a 12-h light/dark cycle (8:00 a.m.-8:00 p.m.). All rats (n=18) were randomly allocated into three groups: control (n=6), model (n=6) and Hyperoxia liquids group (n=6). Pre-treatment with 15 ml/kg hyperoxia liquids for 7 day was intravenous injected into rat of hyperoxia liquids group. After 7 day, rat of model or hyperoxia liquids were anesthetized i.p. with 30 mg/kg sodium pentobarbital (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). Heparin (150 U) and vecuronium bromide (2 mg/kg IV) was induced by switching off the ventilator for 30 min. Resuscitation was started with the initiation of CPB flow and resumption of ventilation. The slipknot was released and rat was received 120 min of reperfusion.
Next, all rats were randomly allocated into four groups (n=24): Control (n=6), model (n=6), Hyperoxia liquids group (n=6) and ML385 (n=6). In ML385 group, pre-treatment with 15 ml/kg Hyperoxia liquids and 5 mg/kg of ML385 for 7 day was intravenous injected into rat of hyperoxia liquids group. Other experimental procedure was invariability. The present study was approved by the Ethical Approval Committee of Shandong Provincial Hospital Affiliated to Shandong University (Shandong, China).
Detection of cardiac function. Rats were anesthetized with 30 mg/kg sodium pentobarbital and a catheter was inserted into the left ventricle, and which was used to measure left ventricular ejection fraction (LVEF) and left ventricular internal dimension systole (LVIDs).
Measurement of serum oxidative stress and tissue caspase-3/8/9 activity. Serum was collected by centrifugation at 1,000 x g for 10 min at 4˚C and used to analyze the levels of malondialdehyde (MDA; S0131), superoxide dismutase (SOD; S0101), glutathione (GSH; S0053), glutathione-peroxidase (GSH-PX; S0056) using ELISK kits (Beyotime Institute of Biotechnology, Nanjing, China). Total proteins of the cell were extracted by using RIPA assay and Protein concentration was estimated by BCA assay. Protein (10 µg) was used to analyze caspase-3/8/9 activity using caspase-3/8/9 activity kits (C1116, C1152, C1158; Beyotime Institute of Biotechnology).
Western blot analysis. Total proteins of the cell were extracted by using RIPA assay and Protein concentration was estimated by BCA assay. Protein (30 µg) was loaded for 10% SDS-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes. The membranes were blocked with 5% non-fat milk in TBS and incubated with Nrf2 (sc-722, 1:1,000; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), HO-1 (sc-10789, 1:1,000; Santa Cruz Biotechnology, Inc.) and GAPDH (sc-25778, 1:1,000; Santa Cruz Biotechnology, Inc.) at 4˚C overnight. The membranes were washed with TBS containing 0.1% Tween-20 and incubated with horseradish peroxidase-conjugated secondary antibodies (sc-2004, 1:5,000; Santa Cruz Biotechnology, Inc.) for 1 h. Protein expression were detected by Amersham ECL Plus Western Blotting Detection kit (GE Healthcare Life Sciences, Piscataway, NJ, USA) and analyzed using Image-ProPlus 6.0 software (Media Cybernetics, Inc., Rockville, MD, USA).
Statistical analysis.
Results are expressed as the mean ± standard error of the mean. Statistical analysis was performed using SPSS 17.0 software (SPSS, Inc., Chicago, IL, USA). Differences between groups were calculated using one-way analysis of variance with Tukey's post-hoc test. P<0.05 was considered to indicate a statistically significant difference.
Results
The effects of hyperoxia liquid regulated heart cell apoptosis in CPB induced rat model. Our study investigated the effects of hyperoxia liquid in regulating heart cell apoptosis in CPB induced rat model. H&E staining showed that heart cell apoptosis in CPB induced rat model was higher than that of control group (Fig. 1A) . The effects of hyperoxia liquid inhibited heart cell apoptosis in CPB rat, compared with CPB induced rat model group (Fig. 1A) . The LVEF was inhibited, and LVIDs level was increased in CPB induced rat model, compared with CPB induced rat model group ( Fig. 1B and C) . Hyperoxia liquid enhanced LVEF and reduced LVIDs level in CPB induced rat model, compared with CPB rat (Fig. 1B and C) . Caspase-3/8/9 activity levels in CPB were elevated, compared with control group (Fig. 1D-F ). In addition, hyperoxia liquid reduced the CPB-induced Caspase-3/8/9 activity levels in rat, compared with CPB induced rat model ( Fig. 1D-F) .
The effects of hyperoxia liquid regulated oxidative stress in CPB induced rat model. We analyzed the effects of hyperoxia liquid on the changes of oxidative stress in CPB induced rat model. As shown in Fig. 2 , MDA level was increased, and SOD, GSH, GAH-PX levels were decreased in CPB, compared with control group. Moreover, the promotion of MDA level, and the inhibition of SOD, GSH, GAH-PX levels were reversed after administration with hyperoxia liquid, compared with CPB induced rat model (Fig. 2) .
The effects of hyperoxia liquid induced Nrf2-ARE signaling pathway in CPB induced rat model. To confirm the mechanism of hyperoxia liquid on oxidative stress in CPB induced rat model, Nrf2-ARE signaling pathway was analyzed using Western blot. As was shown in Fig. 3 , Nrf2 and HO-1 protein expressions were suppressed, while Bax protein expression was induced by hyperoxia liquid in CPB induced rat model, compared with control group. Administration with hyperoxia liquid induced Nrf2 and HO-1 protein expressions, and suppressed Bax protein expression in CPB induced rat model, compared with CPB induced rat model (Fig. 3) .
The inhibition of Nrf2 reduced the function of hyperoxia liquid on Nrf2-ARE signaling pathway in CPB induced rat model. Next, ML385, an Nrf2 inhibitor, was utilized to reduce the function of hyperoxia liquid on Nrf2-ARE signaling pathway in CPB induced rat model. As shown in Fig. 4 , Nrf2 inhibitor suppressed Nrf2 and HO-1 protein expressions, and induced Bax protein expression in CPB induced rat, compared with CPB induced rat model. Treatment with Nrf2 inhibitor suppressed the function of hyperoxia liquid on heart cell apoptosis, the inhibition of LVEF level, promotion of LVIDs level, and caspase-3/8/9 activity levels in CPB induced rat, compared CPB induced rat model (Fig. 5) . Moreover, the inhibition of Nrf2 reduced the function of hyperoxia liquid on the promotion of MDA, and the inhibition of SOD, GSH, GAH-PX levels in CPB induced rat, compared with CPB induced rat model (Fig. 6 ).
Discussion
The myocardial protection technique in hypothermic CPB on-pump open-heart surgery has gradually emerged in recent years (11) . Favorable effects have been achieved in clinic (12) . Meanwhile, it is associated with great drawbacks, such as poor exposure, increased blood return in surgical field and elevated difficulty in surgical operation (12) . In addition, it will lead to increased intracardiac suction, further aggravating the destruction of visible blood components. It will also increase the risk of gas embolism (12) . Meanwhile, ventricular fibrillation may be induced intraoperatively due to the low temperature. CPB myocardial injury is associated with high incidence of arrhythmia. Moreover, the damage mechanism is complicated, which has involved diverse influence factors. These have proposed higher challenges and requirements for clinical prevention and treatment of cardiac surgery. The above measures have been comprehensively applied. However, no expected clinical effect can be attained (12) . Therefore, CPB perioperative myocardial protection remains a research hotspot at present and in the future. In the present study, we demonstrated that the effects of hyperoxia liquid inhibited heart cell apoptosis in CPB induced rat model. Gao et al (13) showed that therapeutic effects of hyperoxia liquid improve systemic oxygenation during one-lung ventilation.
Free radical scavenger refers to substance that can delay, inhibit and block the active oxygen/oxygen radical oxidative injury (14) . It can bind with and scavenge oxygen radicals (15) . ATP reserve in myocardial tissue is reduced during the early myocardial ischemia. Subsequently, it will provide energy through anaerobic metabolism (14) . In early reperfusion, blood flow oxygen cannot be sufficiently used due to the recovery of coronary blood flow (14) . This results in the production of oxygen radicals with potential damage by various oxidase substrates. It leads to excessive accumulation of free radicals. This will then attach the unsaturated fatty acid in membrane phospholipid (16) . Later, it will induce changes in fluidity and permeability of myocardial cell membrane and subcellular organelle membrane (15) . Then, multiple lipid peroxides will be produced, affecting the myocardial cell integrity and function. In addition, it will attack the structural protein of myocardial cell, rendering cleavage of peptide-chain (17) . Oxidative stress is particularly important in CPB and myocardial damage. In the present study, resveratrol was suggested the effects of hyperoxia liquid reduced oxidative stress in CPB induced rat model. Zhao et al (18) suggested that hyperoxia liquid protects against acute hypobaric hypoxia-induced oxidative damage. Karu et al (19) reported that the effects of 60 min of hyperoxia followed by normoxia before coronary artery reduced myocardial injury and inflammatory response profile.
The Nrf2-ARE signaling pathway is recognized to be the most important endogenous anti-oxidative stress pathway (20) . Activation of this pathway can induce the production of antioxidant enzyme and phase II drug metabolic enzyme (21) . It plays a vital role in maintaining intracellular redox state, reducing oxidative damage and protecting cell function. Research finds that the Nrf2-ARE signaling pathway is closely related to improving myocardial I/R injury. Meanwhile, Nrf2 is an important transcription factor in cell to reduce ROS (22) . Our results suggest that the effects of hyperoxia liquid induced Nrf2-ARE signaling pathway in CPB induced rat model. Nrf2 inhibitor, reduced the function of hyperoxia liquid in CPB induced rat model. Karu et al (23) showed that pre-treatment with hyperoxia before coronary artery bypass grafting -effects on myocardial injury and inflammatory response. Nagato et al (24) showed that Hyperoxia promotes polarization of the immune response, and induced Nrf2 and iNOS protein expression. Šarić et al (25) showed that this model of hyperoxia as a useful tool to assess sex differences in adaptive response to acute stress conditions through activation of HO-1 and Nrf2 protein expression. These experiments are three independent experiments, tendency is correct.
Taken together, the results of this study suggest that the effects of hyperoxia liquid inhibited oxidative stress to open heart apoptosis in CPB-induced myocardial damage through Nrf2-ARE signaling pathway ( Fig. 7) . Our present results represent useful tools for the development of a new mode for treatment of CPB-induced myocardial damage. Figure 7 . Effects of hyperoxia liquid regulation of cardiopulmonary bypass-induced myocardial damage through the Nrf2-ARE signaling pathway. ROS, reactive oxygen species; Nrf2, nuclear factor erythroid 2-related factor 2; HO-1, heme oxygenase 1.
